These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35978141)

  • 1. Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1.
    Correia LC; Ferreira JV; de Lima HB; Silva GM; da Silva CHTP; de Molfetta FA; Hage-Melim LIS
    J Mol Model; 2022 Aug; 28(9):258. PubMed ID: 35978141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
    Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
    Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.
    Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X
    J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists.
    Pandey P; Roy KK; Liu H; Ma G; Pettaway S; Alsharif WF; Gadepalli RS; Rimoldi JM; McCurdy CR; Cutler SJ; Doerksen RJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
    Nigro E; Formato M; Crescente G; Daniele A
    Molecules; 2021 May; 26(9):. PubMed ID: 34063214
    [No Abstract]   [Full Text] [Related]  

  • 7. In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling.
    Bodke S; Joshi N; Alavala RR; Suares D
    Comput Biol Chem; 2024 Jun; 110():108049. PubMed ID: 38507844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics.
    Cruz JV; Serafim RB; da Silva GM; Giuliatti S; Rosa JMC; Araújo Neto MF; Leite FHA; Taft CA; da Silva CHTP; Santos CBR
    J Mol Model; 2018 Aug; 24(9):225. PubMed ID: 30088101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of Cannabimovone, a Cannabinoid from
    Iannotti FA; De Maio F; Panza E; Appendino G; Taglialatela-Scafati O; De Petrocellis L; Amodeo P; Vitale RM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32138197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins.
    Sommano SR; Sunanta P; Leksawasdi N; Jantanasakulwong K; Rachtanapun P; Seesuriyachan P; Phimolsiripol Y; Sringarm K; Ruksiriwanich W; Jantrawut P; Chittasupho C
    Molecules; 2022 May; 27(10):. PubMed ID: 35630777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against
    Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.